-
Uncategorized2 months agoSTAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus, but our spirits remain sunny, nonetheless....
-
Uncategorized2 months ago
CVS’ healthcare delivery chief eyes potential in clinical AI
CVS Health has been testing AI tools that deliver healthcare, though it sees too many barriers to using them more widely for now. CVS’ President of...
-
Uncategorized2 months ago
Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth
Eli Lilly’s $19.8 billion revenue for the first quarter could have been higher if not for declining prices for key medicines like Zepbound, Mounjaro and Taltz.
-
Uncategorized2 months ago
Bioprocessing Applications Laboratory Opened in Korea by Ecolab Life Sciences
Officials at Ecolab Life Sciences report that the company is expanding its bioprocessing business with the launch of a new bioprocessing applications lab (BPAL) in Dongtan,...
-
Uncategorized2 months agoSmog from wildfires increasingly harmful, data show
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. If you feel strongly about health...
-
Uncategorized2 months ago
Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study
The patient death occurred outside the U.S. and was deemed unrelated to Newron Pharmaceuticals’ investigational schizophrenia drug.
-
Uncategorized2 months ago
Lack of specifics on obesity pill sales hover over Lilly’s first quarter
Investors hoping for more accurate sales figures for Foundayo, Eli Lilly’s newly launched obesity pill, were disappointed Thursday when the company did not reveal them when...
-
Uncategorized2 months ago
Novartis unveils North Carolina factory as final new build in $23B US expansion
Novartis unveils North Carolina factory as final new build in $23B US expansion
-
Uncategorized2 months agoSTAT+: What does Akeso’s primo plenary spot say about its survival data?
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m suffering from...
-
Uncategorized2 months agoSTAT+: New obesity tool aims to predict risk of 18 serious complications
Body mass index has its limitations, but for now it’s the metric medicine often defaults to when predicting weight-related health problems. A new tool promises to...
